Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromodomain containing 7 pseudogene 3 is classified as a pseudogene in the human genome. It belongs to a group of non-coding genomic sequences that resemble coding genes but are not known to produce functional proteins. BRD7P3 is one of several pseudogenes related to the Bromodomain containing 7 gene (BRD7) but does not encode an active bromodomain protein and has no known role in biological processes, diseases, or as a drug target. It is not considered a therapeutic target, receptor, enzyme, or transporter. The related functional gene, BRD7, encodes a protein involved in chromatin remodeling and transcriptional regulation, including roles in tumor suppression, but BRD7P3 itself is not functional. The target "BRD7P3" is a pseudogene, meaning it is a non-functional genetic locus and not a protein-coding gene, receptor, enzyme, transporter, or transcription factor. It should not be considered a drug target; references to siRNA or knockdown products for BRD7P3 are for experimental use and do not imply it is a therapeutic target. If searching for a relevant drug target, you might consider the true gene Bromodomain containing 7 (BRD7), which is a protein involved in chromatin remodeling and may be implicated in tumor prevention and other biological functions. BRD7P3 (Bromodomain containing 7 pseudogene 3) is a human pseudogene with no known functional protein product, biological function, disease association, or role as a therapeutic target. The entry is best classified as a pseudogene alias, and should not be used as a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain containing 7 pseudogene 3 (BRD7P3).